This was a retrospective reviewing of the charts of patients with metastatic spinal tumors of the CTJ who underwent surgery. Institutional Review Board approval was obtained. From June 2006 to December 2011, 29 patients underwent surgery for spinal tumors involving the cervicothoracic region at a single center by four surgeons comprising two neurosurgeons and two orthopedic surgeons. Our study included the patient undergone surgery of CTJ extending from vertebral segments C7 to T3 according to some previous reports17,21,34). We excluded patients experiencing surgery at the same site, involving C7 vertebra alone and there was not available follow-up data. Also, patients harboring hematologic malignancy, multiple myeloma, and other highly radiosensitive tumors were excluded. Finally, 23 patients were enrolled in our study.

Surgical treatment was considered when the metastatic lesion involved CTJ and this lesion was regarded to correlate with symptoms, for example, intractable pain or neurological deficit. Patients who were not candidates for surgery based on the advanced systemic disease, significant comorbidities, or short life expectancy less than 3 months as predicted by medical oncologists based on general performance and response of chemotherapy were conservatively treated and were not included in the present study. Preoperative work-ups included routine laboratory test, plain X-ray, computed tomography, and magnetic resonance imaging. According to Tomita's classification33), in which lesions are classified according to tumor location inside or outside the anatomical barrier, all patients were classified. Tomita type 1-3 is intra-compartmental type, type 4-6 is extracompartmental, and type 7 is multiple lesions.

Prior to surgery, in cases of hypervascular tumor or large tumor mass, preoperative angiography and tumor embolization was performed to reduce bleeding during the operation by interventional radiologist. Intraoperative monitoring including motor evoked potential and somatosensory evoked potential was used to reduce neurological injury beginning in March, 2008. All patients who underwent CTJ surgery stayed at the intensive care unit postoperatively to cope with acute complication. Surgical techniques used posterior approaches. Posterior approaches including true posterior and posterolateral approach were simple decompression with laminectomy for tumor involved posterior column, laminectomy plus trans-pedicular anterior decompression for tumor located vertebral body and total spondylectomy. For anterior column support, the corpectomy followed by inserting titunum mesh cage or cement block. All procedures were combined with instrumentation including lateral mass screw, or pedicle screw, except for three patients. The extent of tumor resection was classified into radical surgery, debulking surgery in which residual tumor mass was <30% of its primary volume, and simple neural decompression in which residual tumor mass was >30% of its primary volume. The latter two types were considered palliative surgery. Adjuvant radiation therapy (RT) was considered for those not receiving the treatment prior to surgery. Chemotherapy was also performed as another adjuvant treatment option.

Operative chart review identified estimated blood loss (EBL) and length of operation time, major and minor complications, expire date, and last follow-up date. For pain assessment at the preoperative and postoperative periods, we used a visual analogue scale (VAS). Motor status was evaluated by the Medical Research Council (MRC) scale for muscle strength at hospital admission, as well as at follow-up. For prediction of survival period, the Tomita and the revised Tokuhashi scoring system were used. Performance status was evaluated as secondary outcome, and assessed using the Eastern Cooperative Oncology Group (ECOG) scale.

In our institute, all patients were checked using simple X-ray to identify changes in kyphotic angle of the CTJ spine, and to detect possible failure of implants at every 1 month after discharge, except when patient survival was too short or because of follow-up loss. Follow-up ranged from 0.7 to 19.4 months with an average of 5.9 months.

For survival analysis, we calculated follow-up days from surgery to last follow-up date. To clarify of significant variable related with survival, the aforementioned variables used to analyze clinical results were used. For analysis of these outcomes, we used various predictive factors including Tomita and Tokuhashi scores30,32), approach side, extent of resection, whether or not preoperative embolization was performed, and presence of radiation therapy and its timing (RT prior to surgery and RT following surgery).

For investigation of the baseline characteristics of patients, descriptive statistics was used. Comparison of the pain and motor score between preoperative and postoperative status was analyzed by Wilcoxon signed rank test, one-way analysis of variance, or Kruskal-Wallis test. Two sample t-test or Mann-Whitney test was used to test whether or not preoperative embolization was related to intraoperative blood loss. For analysis of overall survival and survival difference between groups, the Kaplan-Meier method and log-rank test were used. Statistical analyses were performed using IBM SPSS 21.0 statistical software (IBM Corp., Armonk, NY, USA). A probability value <0.05 was accepted as statistically significant.

Baseline characteristics of patients are recorded in Table 1. A total of 23 patients underwent resection of CTJ tumors between 35 to 73 years with an average of 54.72 years. There were 17 men and six women. All patients presented with one or both of pain and weakness. MRC scale at hospital admission was grade 3 in 10, grade 4 in 10, and grade 5 in 3 patients. Various primary cancers were metastasized to the spine. The most frequent pathology was lung cancer in six cases, hepatocellular carcinoma in four cases, and colorectal cancer and prostate cancer in three cases respectively. T2 was the most frequent metastatic site followed by T3 and T1. 16 patients had additional metastases of other organ and site (69.6%). All metastatic lesions were Tomita type 4 or higher and 18 patients had multiple spine metastases including Tomita type 6 and 7. 11 patients had a Tomita score exceeding 5 (47.8%). Applying Tokuhashi prognostic score, however, 21 patients (91.3%) were expected to have a poor prognosis (Tokuhashi score <9) (Table 1). In 9 patients, RT was performed prior to surgery as treatment modality for metastatic tumor. In ECOG performance scores before surgery, two patients were ECOG 2, seven were ECOG 3, and fourteen were ECOG 4.

Almost all patients were operated using palliative surgical methods (91.3%, 21/23) that included debulking surgery or simple decompression. 20 patients were instrumented by cervical lateral mass screws and/or pedicle screws including C7 pedicle screw. Of these patients, bone cement and titanium cage was used in two patients to augment vertebral body. Three patients did not require instrumentation.

In fourteen patients, preoperative tumor embolization was undergone without any complications. In patients who underwent preoperative tumor embolization, more intraoperative blood loss was seen (mean EBL in non-embolization group, 715 mL; in embolization group, 810 mL). When considered for only hypervascular tumor including thyroid cancer, hepatocellular carcinoma and renal cell carcinoma, preoperative embolization helps to reduce operative blood loss (mean EBL in non-embolization group 1490 mL; in embolization group, 918 mL). The preoperative embolization group had a shorter operation time than the non-embolization group (non-embolization group, 284.9 min; embolization group, 232.2 min).

Adjuvant radiation therapy was performed in 13 patients after wound healing, including three patients who received preoperative radiation therapy previously. In most patients who underwent radiation therapy, 30 Gy in 10 fraction planning was used. Nine patients including four patients with adjuvant radiation therapy were treated with chemotherapy.

Thirty-day mortality rate were 13.0% (3/23). One lung cancer patient died due to serious disseminated intravascular coagulopathy after severe intraopeative bleeding. Another one cholangiocarcinoma patient with brain metastasis died after posterior surgery due to postoperative pneumonia. One hepatoma patients died with disease progression with acute renal failure, even though his neurological function was good (MRC grade 4).

Postoperative complications were found in ten patients (43.5%). Complications in six patients were related with surgery itself. The other complications were related with systemic causes (Table 2). The most frequent problem was wound problems, precisely wound dehiscence or infection (3/23, 13.0%) in which two patients underwent reoperation. However there was seen no implant failure or aggravation of kyphosis during perioperative period. Fig. 1 summarized trends of postoperative mortality and morbidity during study period.

Table 3 summarized clinical and functional outcomes after surgery. Of the 23 patients of this study, 21 patients showed pain relief according to VAS score after surgery. The other two patients did not complain of pain at initial presentation. Mean postoperative VAS score was significantly reduced compared with mean preoperative status, 2.78 and 7.35, respectively (p<0.001). In the aspect of neurologic recovery, mean MRC grade was significantly improved after surgery (preoperative 2.96, postoperative 3.48, p=0.05).Only one patient showed deterioration of one points MRC grade (preoperative 5, postoperative 4). After surgery, the ECOG either improved or remained unchanged in 22 patients. Specifically, no change between the pre- and post operative ECOG scores was found for one patient. Seventeen patients (73.9%) experienced an improvement in their ECOG score by 1-grade, while two patients (8.7%) experienced an improvement of 2-grades and two patients (8.7%) experienced an improvement of 3-grades.

All patients received RT showed significant pain reduction and improvement of ECOG score regardless of RT timing (Table 3). However, motor strength was significantly recovered only in patients undergone postoperative RT regardless of receiving preoperative RT (p=0.017).

During follow-up, spinal stability were actually achieved in all patients, whilst two patients with adjacent new metastasis had subsequent progressive kyphosis. A case of anterior slippage of mesh cage on X-ray was observed at five months after surgery. There was no new neurological symptom or sign related to progressive kyphosis and slippage of case. The average preoperative kyphosis measured 25° (range, 15-37°). The average Cobb angles in the last follow-up examination was 18° with a range of 12-26°.

Totally, median overall survival was 124 days (95% CI, 50.4-197.6) after surgery (Fig. 2). Additionally, there was no significant difference of survival according to the Tomita and Tokuhashi scores, primary pathology, ambulatory ability, ECOG performance, neurological improvement and extent of resection. Patient who underwent RT had longer survival period compared with patients who did not undergo RT (Fig. 3). Despite primary pathology of prior-RT only group and adjuvant-RT group did not differ, there was no significant survival difference between the prior-RT group and non-prior RT group. However there was significant survival difference between the adjuvant-RT group and non-adjuvant-RT group. Median survivals are 63 days in prior-RT only group (95% CI, 0-150.6) and 186 days (95% CI, 110.1-261.9) in adjuvant-RT only group, respectively.

Combined anterior-posterior approach is indicated in most traumatic lesions involving the CTJ vertebral body13,15,17). In the neoplastic series, however, surgical procedure was usually posterior, because of patients' poor general status and short life expectancy. The anterior approach may be contraindicated in relation to clinical status and/or life expectancy. Especially, the anterior approach to CTJ is technically demanding and some risks and complication may arise. For example, performing a manubriotomy increases surgical time, bleeding, postoperative pain intensity, and length of hospital stay3,10,15). Dissection of the sternoclavicular joint or clavicle resection induces shoulder instability, weakness, and deformity7,9). In patients harboring metastatic tumor, however, the goal of surgery is palliation in most cases, so usually there is no need to bear the risk.

In our study, surgery was performed through the posterior approach, similar to two previous studies about posterior approach about CTJ tumors18,24) that also displayed usefulness of posterior approach, although they were combined primary and metastatic cases.

Generally, posterior approaches are disadvantageous because of a destabilization effect, inadequate visualization of the vertebral body pathology, and the need for a long posterior construct to restore stability with a higher complication rate than anterior or lateral approaches. In neoplastic condition, advantages of this approach include a relative blood and time saving procedure since the main tumor mass is regularly located in the anterior region of the spine, and a rigid fusion even for polysegmental distances.

Concerning the extent of resection, more resection of tumor was associated with a longer median survival time than the limited surgery in thoracic and thoracolumbar metastasis, which was also concluded through an international multicenter prospective observational study12). In addition, Tomita et al.31) reported that local recurrences were absent after total en bloc spondylectomy. However, in the CTJ, radical surgery including en bloc spondylectomy may be difficult due to the aforementioned biomechanical and anatomical reasons. Aggressive surgery showed severe intraoperative blood loss, longer operation time, and more complications. Several recent studies8,23) elucidated the role of limited or palliative surgery. In our study, the degree of surgical resection did not show to significantly alter survival in CTJ spinal metastasis. However, our data support a significant improvement in postoperative overall survival following postoperative radiation. The survival rate of adjuvant RT group was statistically better than that of non RT or prior RT group.

Our surgical results showed high mortality and morbidity rate, even though surgery had a palliative role in the patient's pain and functional outcome. Post-operative complication rate was 43.5% and thirty-day mortality rate was 13% in our study. When compared with previous reports dealing with metastatic spine tumor, these rates are relatively high.

In our study, the most common complication was also wound problems, consistent with another report about metastatic spinal tumors24). Failure of primary healing can lead to wound dehiscence, infection, and neurological compromise. Especially, CTJ has various muscles involved in shoulder movement. Therefore, wound problems like dehiscence could occur frequently. Even in other series, major complications were not found in the anterior approach but in the posterior surgery15,16,17,18,19,34). Poor wound closure technique and postoperative wound infection, although superficial, have played a role. Securing the posterior paraspinal muscles to the remaining cephalad and caudad spinous processes and bringing the fascia closure to midline may also help to reduce this complication.

In addition, preoperative embolization has been useful in reducing blood loss, length of surgery, and postoperative hemorrhage to remove the vertebral body pathology via posterior approach, and spinal angiography does not pose significant procedure-related complications14). In our study, most of medical complication occurred in the early period. Recent improvements of various conservative care and intensive medical care skills have reduced complication rate as seen Fig. 1. As these supports, no more death was due to a surgical complication-related cause during recent 4 years in our series.

Even though the reported functional superiority of the surgical arm has be23), RT as an initial treatment of choice for metastatic spinal tumor showed good clinical outcome including pain reduction and neurologic symptoms11,28). Many institutes select RT as the initial treatment modality, because of surgery-related complications. Naturally, in the case of radiosensitive tumors, the expected survival of less than 3 months and inability of the patient to tolerate an operation, RT is the primary treatment option. Although baseline epidemiological characteristics between the prior-RT group and adjuvant-RT group did not show significant differences in this study, the prior-RT group had no longer survival time than the adjuvant-RT group. A previous report speculated that preoperative radiation may have direct (radiation-induced myelitis) and indirect (reactive gliosis, fibrosis, compromised spinal cord blood supply) effects that may prevent neurological recovery after surgery4). Neurological function, especially ambulatory function, is a factor that has been most consistently cited as determining survival22,26).

Recently, quality of life as well as surgical outcome and survival has been emphasized to treat metastatic spinal tumors6,8,25). This study lacked this analysis. Data on the natural progression in patients with spinal metastasis with palliative care only and the results of nonsurgical treatment are required. Due to the nature of the location, limited and diverse cases were available for this study. A future comprehensive prospective study will need to resolve these limitations.